Literature DB >> 10549756

Colorectal carcinoma in children.

I Karnak1, A O Ciftci, M E Senocak, N Büyükpamukçu.   

Abstract

BACKGROUND/
PURPOSE: Colorecta I carcinoma is extremely rare in children and presents with a poor prognosis. Surgical management and long-term follow-up of this entity are still obscure because of lack of data. Therefore, a retrospective clinical trial was performed to evaluate the clinical characteristics of childhood colorectal carcinoma and to determine the predictors of poor outcome.
METHODS: Records of children who had colorectal carcinoma and were treated at our unit between 1972 and 1997, inclusive, were reviewed retrospectively. Information recorded for each patient included age, sex, clinical characteristics, diagnostic procedures, extent of disease, treatment methods, histological types, and outcome. A modified Dukes staging scheme was used.
RESULTS: There were 12 boys and 8 girls who were treated for colorectal carcinoma (range, 7 to 16 years). Predisposing conditions were encountered in 2 patients (10%), one with Bloom's syndrome and another with familial occurrence of colonic carcinomas. Predominant symptoms were abdominal pain, vomiting, and rectal bleeding. Barium enema, ultrasonography, computerized tomography, and endoscopic procedures were used for the diagnosis. Rectosigmoid region was the most common site for the primary tumor (65%). All patients presented with advanced stages of disease (stage C, 7; stage D, 13). Surgical procedures were incisional biopsy (n = 4), palliative permanent colostomy (n = 4), segmental resection (n = 5), complete resection (n = 6), and rectal biopsy (n = 1). Peritoneum was the most common site of extensive intraabdominal disease followed by omentum majus and liver. The lung also was involved in 2 patients. Predominant histological type was mucinous adenocarcinoma (80%). All patients but one received adjuvant chemotherapy, and 2 received palliative radiotherapy. Thirteen patients died of disease in a period ranging from 1 day to 1 year after initial surgery. The fate of 4 patients who were discharged in a very ill status was unknown. Three patients were alive for 2 years to 4 years postoperatively, and one of them presented with end stage disease.
CONCLUSIONS: Delayed diagnosis, advanced stages of disease at presentation, and, most importantly, mucinous type of histology are the major determinants of poor outcome in childhood colorectal carcinoma. We emphasize that possibility of a malignant colorectal tumor should be considered for any childhood case with signs and symptoms of intestinal obstruction, intractable abdominal pain, alteration in bowel habits and gastrointestinal bleeding. Colorectal malignancy should not be excluded only on the basis of the patient's age. Because of the steadily increasing incidence of precancerous bowel diseases and poor prognosis of colorectal carcinoma, childhood cases of bowel disorders should receive the same detailed and vigorous diagnostic evaluation and appropriate treatment as given to adult cases. Contrast studies, ultrasonography, computed tomography, and endoscopy are essential procedures for both confirming the diagnosis and detecting the extent of the disease.

Entities:  

Mesh:

Year:  1999        PMID: 10549756     DOI: 10.1016/s0022-3468(99)90112-4

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  18 in total

1.  Colorectal cancer with neuroendocrine differentiation in a child.

Authors:  Carlo Angelini; Stefano Crippa; Fabio Uggeri; Claudia Bonardi; Paola Sartori; Franco Uggeri
Journal:  Pediatr Surg Int       Date:  2005-10-21       Impact factor: 1.827

2.  Signet-ring cell carcinoma of the colon: A case report of a 9-year-old boy.

Authors:  Shaobo Yang; Gongbao Liu; Shan Zheng; Kuiran Dong; Yangyang Ma; Xianmin Xiao
Journal:  Oncol Lett       Date:  2015-06-22       Impact factor: 2.967

3.  Colonic adenocarcinoma as a secondary malignancy after treatment of embryonal rhabdomyosarcoma.

Authors:  Moustafa Hamchou; Hilal Matta; Gabriel Ionescu; Adnan Swid; Ahmed H Al-Salem
Journal:  World J Pediatr       Date:  2011-08-27       Impact factor: 2.764

Review 4.  Colon carcinoma in childhood: review of the literature with four case reports.

Authors:  Gangmi Kim; Seung Hyuk Baik; Kang Young Lee; Hyuk Hur; Byung Soh Min; Chuhl Joo Lyu; Nam Kyu Kim
Journal:  Int J Colorectal Dis       Date:  2012-10-26       Impact factor: 2.571

Review 5.  Colorectal carcinoma in the first decade of life: a systematic review.

Authors:  René Aloisio da Costa Vieira; Maiara Silva Tramonte; Luiz Fernando Lopes
Journal:  Int J Colorectal Dis       Date:  2015-04-28       Impact factor: 2.571

Review 6.  Epidemiology and management options for colorectal cancer in children.

Authors:  Raya Saab; Wayne L Furman
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022

7.  Fifteen-year-old colon cancer patient with a 10-year history of ulcerative colitis.

Authors:  Seung Yeon Noh; Seung Young Oh; Soo-Hong Kim; Hyun-Young Kim; Sung-Eun Jung; Kwi-Won Park
Journal:  World J Gastroenterol       Date:  2013-04-21       Impact factor: 5.742

8.  Colon mucinous adenocarcinoma in childhood: a case report with emphasis on image findings.

Authors:  Antonio Muccillo; Edson Marchiori; Cláudia Renata Penna; Regina Rodrigues Guimarães; Gláucia Zanetti; Guilherme Abdalla; Nina Ventura; Carolina Lamas Constantino; Mariana Leite Pereira; Viviane Brandão; Pedro Martins; Rodrigo Canellas; Romulo Varella de Oliveira
Journal:  Case Rep Med       Date:  2010-03-25

9.  Colon carcinoma in children and adolescents: prognostic factors and outcome-a review of 11 cases.

Authors:  Sonia Salas-Valverde; Andrea Lizano; Yessica Gamboa; Sergio Vega; Max Barrantes; Silvia Santamaría; Jose Barrantes Zamora
Journal:  Pediatr Surg Int       Date:  2009-10-09       Impact factor: 1.827

10.  Colorectal carcinoma in first decade of life: our experience.

Authors:  M A Mushfiqur Rahman; Tanvir K Chowdhury; Md Akbar Husain Bhuiyan; Md Abdullah Al Farooq; Md Minhajuddin Sajid; Tahmina Banu
Journal:  Pediatr Surg Int       Date:  2014-07-09       Impact factor: 1.827

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.